Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Ischemic Heart Disease

Free Subscription Articles published in J Mol Cell Cardiol Retrieve available abstracts of 62 articles: HTML format

Single Articles

August 2026
1. LIU L, Niu W, Jia Y, Zhang Q, et al
   Icosapent ethyl activates GPR120 to improve post-myocardial infarction cardiac remodeling by suppressing CXCR3(+) inflammatory cells.
   J Mol Cell Cardiol. 2026 Aug 21:S0022-2828(26)00128.
   PubMed     Abstract available
   
   
   
2. ZHANG G, Wu Y, Lin H
   Site-specific O-GlcNAcylation of Nrf2 regulates myocardial ischemia-reperfusion injury.
   J Mol Cell Cardiol. 2026 Aug 20:S0022-2828(26)00126.
   PubMed     Abstract available
   
   
   
3. WANG A, Qin B, Lee MCJ, Zhu Y, et al
   PP2Acalpha regulates the Hippo-YAP signaling axis to promote cardiac regeneration and alleviate myocardial infarction.
   J Mol Cell Cardiol. 2026 Aug 18:S0022-2828(26)00127.
   PubMed     Abstract available
   
   
   July 2026
4. JIE L, Zhou T, Li G, Shen W, et al
   Melatonin promotes coronary angiogenesis and ameliorates cardiac dysfunction after myocardial infarction via endothelial LRRC8A.
   J Mol Cell Cardiol. 2026 Jul 9:S0022-2828(26)00104.
   PubMed     Abstract available
   
   
   June 2026
5. SOLGA I, Gotzmann L, Yogathasan V, Wischmann P, et al
   Large extracellular vesicles derived from red blood cells in coronary artery disease patients with anemia promote endothelial dysfunction.
   J Mol Cell Cardiol. 2026 Jun 26:S0022-2828(26)00095.
   PubMed     Abstract available
   
   
   
6. CHEN Y, Zheng L, Xiong C, Wang Z, et al
   Small-molecule cocktail 5SM induces heart regeneration by upregulating TGFbeta/BMP signaling.
   J Mol Cell Cardiol. 2026;215:20-35.
   PubMed     Abstract available
   
   
   
7. YAN Y, Huang Y, Cao C, Li D, et al
   OSK-mediated partial reprogramming induces cardiomyocyte dedifferentiation, overcomes cytokinesis barriers, and promotes post-MI endogenous cardiac regeneration.
   J Mol Cell Cardiol. 2026;215:36-50.
   PubMed     Abstract available
   
   
   May 2026
8. ZHOU H, Christopher CJ, Jones K, Pla MM, et al
   Myocardial metabolic remodeling in human end-stage ischemic and non-ischemic cardiomyopathy.
   J Mol Cell Cardiol. 2026;214:17-27.
   PubMed     Abstract available
   
   
   
9. ROMAN B, Petersen CE, Sun J, Murphy E, et al
   Sex differences in mitochondrial Ca(2+) during ischemia/reperfusion injury: A role for S-Nitrosylation.
   J Mol Cell Cardiol. 2026;214:1-10.
   PubMed     Abstract available
   
   
   April 2026
10. DHALLA NS, Patel CA, Beladiya JV, Mehta AA, et al
    Pathophysiology and pharmacotherapy of cardiovascular complications in metabolic syndrome.
    J Mol Cell Cardiol. 2026 Apr 23:S0022-2828(26)00058.
    PubMed     Abstract available
    
    
    
11. MOSCARELLI M, Skeffington KL, Fudulu D, Punjabi P, et al
    Left and right myocardial ventricular energetics during cardioplegic ischemic arrest and reperfusion in patients undergoing cardiac surgery.
    J Mol Cell Cardiol. 2026;213:84-92.
    PubMed     Abstract available
    
    
    
12. DE OLIVEIRA DF, Maciel L, Dos Santos Silva A, Da Coutinho KC, et al
    The C-domain of the cerebral dopamine neurotrophic factor (CDNF) is responsible for its cardioprotective activity by binding to the KDEL receptor relocated to the plasma membrane under endoplasmic reticulum stress conditions.
    J Mol Cell Cardiol. 2026;213:32-47.
    PubMed     Abstract available
    
    
    February 2026
13. DONG K, Zuo Y, Yao Y, He X, et al
    Coronary artery disease risk gene PRDM16 regulates smooth muscle homeostasis.
    J Mol Cell Cardiol. 2026;213:74-83.
    PubMed     Abstract available
    
    
    
14. ZHOU MM, Xu L, Huang DZ, Wang X, et al
    KCNQ2 downregulation in left stellate ganglion neurons exacerbates malignant ventricular arrhythmias after myocardial infarction.
    J Mol Cell Cardiol. 2026;213:59-73.
    PubMed     Abstract available
    
    
    January 2026
15. GUMZ ML, Eikenberry SA
    Watching the clock: Blood pressure and cardiovascular disease influence circadian machinery in pre-clinical models.
    J Mol Cell Cardiol. 2026 Jan 2:S0022-2828(25)00236.
    PubMed     Abstract available
    
    
    
16. YUCEL D, Smith C, Ferreira de Araujo N, Souza-Neto F, et al
    Small-scale siRNA screen reveals WWC2 as a novel regulator of cardiomyocyte mitosis.
    J Mol Cell Cardiol. 2026;210:127-136.
    PubMed     Abstract available
    
    
    
17. YANG J, Cheng S, Chong H, Zong Q, et al
    Cardiac fibroblasts-specific USP7 drives post-infarction cardiac fibrosis by deubiquitinating Kruppel-like factor 7 to promote myofibroblast activation.
    J Mol Cell Cardiol. 2026;210:109-126.
    PubMed     Abstract available
    
    
    December 2025
18. SANCHEZ-LOPEZ D, Garcia-Vega D, Vinuela JE, Ferreiros-Vidal I, et al
    Corrigendum to 'FABP4, marker of worse prognosis in cardiovascular disease, induces neutrophil's proatherogenic phenotype which is modulated by semaglutide' [Journal of Molecular and Cellular Cardiology volume 210 (2026) 12-27].
    J Mol Cell Cardiol. 2025;211:63.
    PubMed    
    
    
    
19. CHU Y, Zhu J, Chen S, Lin X, et al
    Beneficial effects of aryl hydrocarbon receptor activation on post-infarction myocardial metabolism, inflammation and fibrosis: implications from multi-omics.
    J Mol Cell Cardiol. 2025;209:104-118.
    PubMed     Abstract available
    
    
    November 2025
20. ZHAO L, Cao Y, Liu X, Yang Q, et al
    ZIP14 upregulation leads to ferroptosis and lysosomal dysfunction through intracellular iron overload and induces myocardial ischemia/reperfusion injury in mouse hearts.
    J Mol Cell Cardiol. 2025 Nov 27:S0022-2828(25)00219.
    PubMed     Abstract available
    
    
    
21. WONG D, Tran M, Martinez J, Avila I, et al
    Slit2-robo signaling regulates angiogenesis and repair following myocardial infarction.
    J Mol Cell Cardiol. 2025;210:28-42.
    PubMed     Abstract available
    
    
    
22. SANCHEZ-LOPEZ D, Garcia-Vega D, Vinuela JE, Ferreiros-Vidal I, et al
    FABP4, marker of worse prognosis in cardiovascular disease, induces neutrophil's proatherogenic phenotype which is modulated by semaglutide.
    J Mol Cell Cardiol. 2025 Nov 1:S0022-2828(25)00193.
    PubMed     Abstract available
    
    
    October 2025
23. SHUMLIAKIVSKA M, Fischer A, Muhly-Reinholz M, Leonard VE, et al
    The long non-coding RNA Snhg15 protects the heart after myocardial infarction.
    J Mol Cell Cardiol. 2025 Oct 27:S0022-2828(25)00195.
    PubMed     Abstract available
    
    
    
24. WANG Y, Li Y, Zhou Y, Zhang H, et al
    Nynrin enhances cardiac function by inhibiting mitochondrial permeability transition pore opening upon myocardial ischemia/reperfusion injury.
    J Mol Cell Cardiol. 2025 Oct 10:S0022-2828(25)00180.
    PubMed     Abstract available
    
    
    
25. SUN Z, Li N, Huang M, Li Y, et al
    Myofibroblast specific knockdown of NSUN2 suppresses cardiac fibrosis post-myocardial infarction.
    J Mol Cell Cardiol. 2025;209:27-36.
    PubMed     Abstract available
    
    
    
26. ALI SR, Nguyen NUN, Elhelaly W, Hsu CC, et al
    Paracrine IGFBP3 spatially coordinates IGF signaling to induce myocardial regeneration in mice.
    J Mol Cell Cardiol. 2025;207:93-106.
    PubMed     Abstract available
    
    
    September 2025
27. THOMAS D, Yang PC, Wu JC, Sayed N, et al
    Decoding long COVID-associated cardiovascular dysfunction: Mechanisms, models, and new approach methodologies.
    J Mol Cell Cardiol. 2025 Sep 30:S0022-2828(25)00178.
    PubMed     Abstract available
    
    
    
28. CHOI JS, Pervin M, Vince JE, Sharma A, et al
    Targeting the NLRP3 Inflammasome-Gasdermin D Axis to Combat Cardiovascular Diseases.
    J Mol Cell Cardiol. 2025;209:1-14.
    PubMed     Abstract available
    
    
    
29. CHEN Z, Yu X, Ke M, Li H, et al
    Corrigendum to "Human embryonic stem cell-derived cardiovascular progenitor cells stimulate cardiomyocyte cell cycle activity via activating the PI3K/Akt pathway" [J. Mol. Cell. Cardiol. 197 (2024) 5-10.].
    J Mol Cell Cardiol. 2025;208:32-34.
    PubMed    
    
    
    
30. JIANG Y, Estau D, Qiao Y, Li Z, et al
    14-3-3/HIP-55 complex attenuates cardiomyocyte apoptosis.
    J Mol Cell Cardiol. 2025;206:91-101.
    PubMed     Abstract available
    
    
    July 2025
31. WELLS CK, Nguyen DC, Brainard RE, McNally LA, et al
    Pyruvate kinase splice variants in fibroblasts influence cardiac remodeling after myocardial infarction in male mice.
    J Mol Cell Cardiol. 2025;206:11-26.
    PubMed     Abstract available
    
    
    
32. MELKANI GC
    Time-restricted feeding mediated synchronization of circadian rhythms to sustain cardiovascular health.
    J Mol Cell Cardiol. 2025;206:1-10.
    PubMed     Abstract available
    
    
    
33. GIBBS CE, Boyle PM
    Population-based computational simulations elucidate mechanisms of focal arrhythmia following stem cell injection.
    J Mol Cell Cardiol. 2025;204:5-16.
    PubMed     Abstract available
    
    
    April 2025
34. SEVERINO P, D'Amato A, Prosperi S, Myftari V, et al
    Coronary microcirculation in myocardial ischemia: A genetic perspective.
    J Mol Cell Cardiol. 2025 Apr 10:S0022-2828(25)00060.
    PubMed     Abstract available
    
    
    March 2025
35. PYLE WG
    Heartbreak and trauma: Unraveling sex-specific effects of post-traumatic stress disorder on cardiovascular disease.
    J Mol Cell Cardiol. 2025;202:153-154.
    PubMed    
    
    
    
36. GASPAR LS, Pyakurel S, Xu N, D'Souza SP, et al
    Circadian biology in obstructive sleep apnea associated cardiovascular disease.
    J Mol Cell Cardiol. 2025 Mar 17:S0022-2828(25)00054.
    PubMed     Abstract available
    
    
    
37. ROBERTS TD, Hutchinson DS, Wootten D, De Blasio MJ, et al
    Advances in incretin therapies for targeting cardiovascular disease in diabetes.
    J Mol Cell Cardiol. 2025;202:102-115.
    PubMed     Abstract available
    
    
    January 2025
38. SHABANI P, Dong F, Yun J, Shin SY, et al
    Does coronary microvascular dysfunction play a role in heart failure with reduced ejection fraction?
    J Mol Cell Cardiol. 2025 Jan 28:S0022-2828(25)00007.
    PubMed     Abstract available
    
    
    
39. AUDAM TN, Howard CM, Little DT, Garrett LF, et al
    Hyaluronan provokes inflammation but suppresses phagocytotic function in macrophages.
    J Mol Cell Cardiol. 2025;198:24-35.
    PubMed     Abstract available
    
    
    December 2024
40. FLORES RC, Yaffe R, Nhunzwi MM, Nguyen H, et al
    Maternal shift work during pregnancy and cardiovascular health impacts on mother and offspring.
    J Mol Cell Cardiol. 2024 Dec 21:S0022-2828(24)00213.
    PubMed     Abstract available
    
    
    
41. HYTONEN JP, Pajula J, Halonen P, Taavitsainen J, et al
    Endothelialization of coronary stents after intra-luminal adenoviral VEGF-A gene transfer in a preclinical porcine restenosis model - Studies with optical coherence tomography, angioscopy, multiphoton and scanning electron microscopy.
    J Mol Cell Cardiol. 2024 Dec 18:S0022-2828(24)00212.
    PubMed     Abstract available
    
    
    November 2024
42. BASSIOUNI W, Mahmud Z, Simmen T, Seubert JM, et al
    MMP-2 inhibition attenuates ER stress-mediated cell death during myocardial ischemia-reperfusion injury by preserving IRE1alpha.
    J Mol Cell Cardiol. 2024;198:74-88.
    PubMed     Abstract available
    
    
    
43. JIMENEZ-TELLEZ N, Williams D, Liu Y, Wang M, et al
    Transcriptomic analysis of nicotine on the cardiovascular system using a diverse population of human induced pluripotent stem cell-derived endothelial cells.
    J Mol Cell Cardiol. 2024;198:21-23.
    PubMed    
    
    
    
44. LI R, Hanna A, Huang S, Hernandez SC, et al
    Macrophages in the infarcted heart acquire a fibrogenic phenotype, expressing matricellular proteins, but do not undergo fibroblast conversion.
    J Mol Cell Cardiol. 2024;196:152-167.
    PubMed     Abstract available
    
    
    October 2024
45. CHEN Z, Yu X, Ke M, Li H, et al
    Human embryonic stem cell-derived cardiovascular progenitor cells stimulate cardiomyocyte cell cycle activity via activating the PI3K/Akt pathway.
    J Mol Cell Cardiol. 2024 Oct 9:S0022-2828(24)00163.
    PubMed     Abstract available
    
    
    
46. STURNY R, Boulgakoff L, Kelly RG, Miquerol L, et al
    Transient formation of collaterals contributes to the restoration of the arterial tree during cardiac regeneration in neonatal mice.
    J Mol Cell Cardiol. 2024;195:1-13.
    PubMed     Abstract available
    
    
    September 2024
47. PENG Y, Jiang Y, Zhou Q, Jia Z, et al
    SGK1 contributes to ferroptosis in coronary heart disease through the NEDD4L/NF-kappaB pathway.
    J Mol Cell Cardiol. 2024 Sep 6:S0022-2828(24)00143.
    PubMed     Abstract available
    
    
    August 2024
48. GUTIERREZ-AGUILAR M, Klutho PJ, Aguayo-Ortiz R, Song L, et al
    Endogenous complement 1q binding protein (C1qbp) regulates mitochondrial permeability transition and post-myocardial infarction remodeling and dysfunction.
    J Mol Cell Cardiol. 2024 Aug 27:S0022-2828(24)00140.
    PubMed     Abstract available
    
    
    
49. YI J, Chen K, Cao Y, Wen C, et al
    Up-regulated novel-miR-17 promotes hypothermic reperfusion arrhythmias by negatively targeting Gja1 and mediating activation of the PKC/c-Jun signaling pathway.
    J Mol Cell Cardiol. 2024;193:1-10.
    PubMed     Abstract available
    
    
    July 2024
50. LAHIRI SK, Lu J, Aguilar-Sanchez Y, Li H, et al
    Targeting Calpain-2-mediated Junctophilin-2 cleavage delays heart failure progression following myocardial infarction.
    J Mol Cell Cardiol. 2024 Jul 1:S0022-2828(24)00108.
    PubMed     Abstract available
    
    
    June 2024
51. SENTHILKUMAR G, Hammond ST, Zirgibel Z, Cohen KE, et al
    Is the peripheral microcirculation a window into the human coronary microvasculature?
    J Mol Cell Cardiol. 2024;193:67-77.
    PubMed     Abstract available
    
    
    May 2024
52. KISKIN FN, Yang Y, Yang H, Zhang JZ, et al
    Cracking the code of the cardiovascular enigma: hPSC-derived endothelial cells unveil the secrets of endothelial dysfunction.
    J Mol Cell Cardiol. 2024;192:65-78.
    PubMed     Abstract available
    
    
    
53. MCCALLINHART PE, Chade AR, Bender SB, Trask AJ, et al
    Expanding landscape of coronary microvascular disease in co-morbid conditions: Metabolic disease and beyond.
    J Mol Cell Cardiol. 2024;192:26-35.
    PubMed     Abstract available
    
    
    
54. DE WINTER N, Ji J, Sintou A, Forte E, et al
    Persistent transcriptional changes in cardiac adaptive immune cells following myocardial infarction: New evidence from the re-analysis of publicly available single cell and nuclei RNA-sequencing data sets.
    J Mol Cell Cardiol. 2024;192:48-64.
    PubMed     Abstract available
    
    
    
55. MA X, Zhao J, Feng Y
    Epicardial SMARCA4 deletion exacerbates cardiac injury in myocardial infarction and is related to the inhibition of epicardial epithelial-mesenchymal transition.
    J Mol Cell Cardiol. 2024;191:76-87.
    PubMed     Abstract available
    
    
    
56. SUN H, Wang X, Pratt RE, Dzau VJ, et al
    C166 EVs potentiate miR cardiac reprogramming via miR-148a-3p.
    J Mol Cell Cardiol. 2024;190:48-61.
    PubMed     Abstract available
    
    
    April 2024
57. CREA F, Iannaccone G, La Vecchia G, Montone RA, et al
    An update on the mechanisms of Takotsubo syndrome: "At the end an acute coronary syndrome".
    J Mol Cell Cardiol. 2024 Apr 17:S0022-2828(24)00053.
    PubMed     Abstract available
    
    
    March 2024
58. DU C, Zhao S, Shan T, Han X, et al
    Cellular nucleic acid binding protein facilitates cardiac repair after myocardial infarction by activating beta-catenin signaling.
    J Mol Cell Cardiol. 2024;189:66-82.
    PubMed     Abstract available
    
    
    
59. NGUYEN T, Rosa-Garrido M, Sadek H, Garry DJ, et al
    Promoting cardiomyocyte proliferation for myocardial regeneration in large mammals.
    J Mol Cell Cardiol. 2024;188:52-60.
    PubMed     Abstract available
    
    
    
60. CAO X, Thomas D, Whitcomb LA, Wang M, et al
    Modeling ionizing radiation-induced cardiovascular dysfunction with human iPSC-derived engineered heart tissues.
    J Mol Cell Cardiol. 2024;188:105-107.
    PubMed    
    
    
    February 2024
61. ANTIPENKO S, Mayfield N, Jinno M, Gunzer M, et al
    Neutrophils are indispensable for adverse cardiac remodeling in heart failure.
    J Mol Cell Cardiol. 2024;189:1-11.
    PubMed     Abstract available
    
    
    October 2023
62. XIAO Z, Wei X, Li M, Yang K, et al
    Myeloid-specific deletion of Capns1 attenuates myocardial infarction injury via restoring mitochondrial function and inhibiting inflammasome activation.
    J Mol Cell Cardiol. 2023;183:54-66.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum